S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa

IRadimed Stock Price, News & Analysis (NASDAQ:IRMD)

$41.73
-0.05 (-0.12%)
(As of 12/8/2023 ET)
Compare
Today's Range
$41.25
$42.39
50-Day Range
$37.31
$45.06
52-Week Range
$27.57
$51.04
Volume
20,929 shs
Average Volume
26,645 shs
Market Capitalization
$526.22 million
P/E Ratio
32.35
Dividend Yield
N/A
Price Target
$54.00

IRadimed MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
29.4% Upside
$54.00 Price Target
Short Interest
Healthy
1.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.59mentions of IRadimed in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.76 M Sold Last Quarter
Proj. Earnings Growth
19.12%
From $1.36 to $1.62 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.26 out of 5 stars

Medical Sector

11th out of 932 stocks

Surgical & Medical Instruments Industry

4th out of 93 stocks


IRMD stock logo

About IRadimed Stock (NASDAQ:IRMD)

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IRMD Stock Price History

IRMD Stock News Headlines

Why We Like The Returns At IRadimed (NASDAQ:IRMD)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
iRadimed Corp IRMD
5 Small Hidden Gems for the Rest of 2023
IRadimed: Which Way Now
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
IRadimed: Q3 Earnings Snapshot
iRadimed's Earnings: A Preview
Here's what to expect from iRadimed's earnings report
Iradimed Corp
See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2023
Today
12/09/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/01/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
123
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$54.00
High Stock Price Target
$60.00
Low Stock Price Target
$48.00
Potential Upside/Downside
+29.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$12.83 million
Pretax Margin
32.97%

Debt

Sales & Book Value

Annual Sales
$53.30 million
Cash Flow
$1.07 per share
Book Value
$5.86 per share

Miscellaneous

Free Float
7,238,000
Market Cap
$526.22 million
Optionable
Not Optionable
Beta
0.87
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Roger E. Susi (Age 70)
    Founder, Chairman, CEO & President
    Comp: $586.04k
  • Mr. John F. Glenn (Age 61)
    CFO & Corporate Secretary
    Comp: $411.79k
  • Mr. Randy Waddell
    Vice President of Worldwide Sales & Marketing
  • Mr. Steve Kachelmeyer
    Vice President of Regulatory Affairs & Quality Assurance
  • Mr. Lynn Neuhardt
    Vice President of Research & Development
  • Mr. Chris Williamson
    Executive Vice President of Continuous Improvement & Information Technology
  • Mr. Matt Garner
    Controller














IRMD Stock Analysis - Frequently Asked Questions

Should I buy or sell IRadimed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings
or view top-rated stocks.

What is IRadimed's stock price target for 2024?

1 Wall Street analysts have issued 1-year price objectives for IRadimed's shares. Their IRMD share price targets range from $48.00 to $60.00. On average, they expect the company's share price to reach $54.00 in the next year. This suggests a possible upside of 29.4% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2023?

IRadimed's stock was trading at $28.29 at the start of the year. Since then, IRMD stock has increased by 47.5% and is now trading at $41.73.
View the best growth stocks for 2023 here
.

Are investors shorting IRadimed?

IRadimed saw a drop in short interest in November. As of November 15th, there was short interest totaling 80,000 shares, a drop of 19.8% from the October 31st total of 99,700 shares. Based on an average daily trading volume, of 33,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.1% of the company's stock are sold short.
View IRadimed's Short Interest
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) announced its quarterly earnings data on Friday, November, 3rd. The medical equipment provider reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.06. The medical equipment provider earned $16.51 million during the quarter, compared to analyst estimates of $16.21 million. IRadimed had a net margin of 25.92% and a trailing twelve-month return on equity of 23.19%.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed declared a dividend on Monday, February 6th. Stockholders of record on Monday, February 13th will be given a dividend of $1.05 per share on Tuesday, February 21st. This represents a yield of 2.54%. The ex-dividend date is Friday, February 10th. This is a boost from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD
.

What ETF holds IRadimed's stock ?

Ballast Small/Mid Cap ETF holds 19,404 shares of IRMD stock, representing 0.98% of its portfolio.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

Who are IRadimed's major shareholders?

IRadimed's stock is owned by many different institutional and retail investors. Top institutional investors include RK Capital Management LLC (2.39%), Ranger Investment Management L.P. (1.68%), Northern Trust Corp (0.66%), Rice Hall James & Associates LLC (0.61%), Bank of New York Mellon Corp (0.44%) and Los Angeles Capital Management LLC (0.42%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IRMD) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -